Ligand profile
CHEMBL1383244
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_02160 — Phosphoglycerate kinase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1383244- UniProt (similar protein)
Q4GZG4- Target protein
- KP13_02160
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 53.8
- −1 ≤ LogP ≤ 5 2.21
- MW ≤ 500 Da 304.4
- LogP ≤ 5 2.21
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 53.8
Matches PAINS filter: ene_six_het_A(483). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
CCN1C(=O)C(=C/C=C/c2ccco2)C(=O)N(CC)C1=SCCN1C(=O)C(=C/C=C/c2ccco2)C(=O)N(CC)C1=S
InChI=1S/C15H16N2O3S/c1-3-16-13(18)12(14(19)17(4-2)15(16)21)9-5-7-11-8-6-10-20-11/h5-10H,3-4H2,1-2H3/b7-5+InChI=1S/C15H16N2O3S/c1-3-16-13(18)12(14(19)17(4-2)15(16)21)9-5-7-11-8-6-10-20-11/h5-10H,3-4H2,1-2H3/b7-5+
ZNPAAXBUUDAILM-FNORWQNLSA-NZNPAAXBUUDAILM-FNORWQNLSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- active
- Binding sites
- PF00162
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1383244 →
- UniProt UniProt Q4GZG4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1383244”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02160.
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).